Shorter duration, fully oral treatment regimens for tuberculosis (TB) are now recommended for most adults and children. Updated joint guidelines from the American Thoracic Society, the CDC, European ...

For decades, patients being treated for drug-resistant tuberculosis have had to endure a gruelling regimen of daily injections and a cocktail of drugs with severe side effects.

Tuberculosis (TB) is a major unrecognized cause of deadly sepsis among people with HIV in Africa, a sweeping new study reveals. Beginning treatment for TB immediately – even before sepsis patients are ...

This World Tuberculosis (TB) Day, Médecins Sans Frontières (MSF) urges governments and international donors to bring children to the heart of the global TB response, and commit to investing in the ...

Tuberculosis can recur through relapse or new drug-resistant strains, often triggered by incomplete treatment, a weakened ...

Tuberculosis resurfaced into the national spotlight recently with a sudden resurgence of cases early this year.

The World Health Organization (WHO) called on Tuesday for countries to step up action to end tuberculosis (TB) – one of the ...

India has launched the world’s first clinical trial to study Ayurveda alongside standard TB treatment. The trial will assess ...

In 2022, World Health Organization (WHO) recommended a shorter six-month, all-oral regimen known as BPaL (M), making ...

On the occasion of World Tuberculosis Day, India announced the world’s first clinical study to scientifically evaluate ...